Drug Eluting Balloons Catheters Market Growth Outlook Through 2024-2033

A drug-eluting balloon catheter is a medical device used to treat coronary artery disease by percutaneous coronary intervention (PCI). It is a semi-compliant angioplasty balloon coated with an anti-proliferative drug that is released into the vessel wall during inflation, which helps to prevent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object.

Sizing and Forecast
The drug eluting balloons catheters market size has grown rapidly in recent years. It will grow from $1.23 billion in 2023 to $1.43 billion in 2024 at a compound annual growth rate (CAGR) of 16.3%.  The  growth in the historic period can be attributed to increasing respiratory disorders, advantages over traditional inhalers, patient preference for dpis, government initiatives for respiratory health, strategic collaborations and partnerships, advancements in drug formulations, rising geriatric population..

The drug eluting balloons catheters market size is expected to see rapid growth in the next few years. It will grow to $2.35 billion in 2028 at a compound annual growth rate (CAGR) of 13.2%.  The growth in the forecast period can be attributed to continued growth in respiratory disorders, expanding geriatric population, increasing awareness and education, market expansion in emerging economies, customized drug formulations, regulatory support and compliance, innovations in packaging and design.. Major trends in the forecast period include smart inhalers and connectivity, shift towards breath-actuated inhalers, focus on pediatric and geriatric patient needs, biologics delivery, environmentally friendly inhaler designs..

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report

Segmentation & Regional Insights
The drug eluting balloons catheters market covered in this report is segmented –

1) By Product: Coronary Artery Disease Drug-Eluting Balloon Catheters, Peripheral Vascular Disease Drug-Eluting Balloon Catheters
2) By Drug: Paclitaxel, Sirolimus, Other Drugs
3) By Raw Material: Nylon, Polyurethane, Other Raw Materials
4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Catheterization Laboratories

North America was the largest region in the drug eluting balloons catheters market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13429&type=smp

Major Driver Impacting Market Growth
The growing prevalence of peripheral and cardiovascular diseases is expected to propel the growth of the drug-eluting balloon catheter market going forward. Cardiovascular diseases (CVDs) refer to a group of conditions that impact the heart and the circulatory system, whereas peripheral artery disease (PAD) specifically refers to a condition where narrowed arteries reduce blood flow primarily to the arms or legs. Drug-eluting balloon catheters are a type of treatment for coronary artery disease (CAD) that uses a semi-compliant angioplasty balloon coated with an anti-proliferative substance that, when it enters the vessel, can have an anti-restenotic effect. For instance, in April 2023, according to the British Heart Foundation, a UK-based cardiovascular research charity, the number of deaths from coronary heart disease in the UK in 2021 was 65,579, up from 64,170 in 2020. Furthermore, in April 2023, according to HMP Global, a US-based multi-accredited patient-centered education company, it is projected that the prevalence of peripheral arterial disease in the US will reach 23.8 million in 2030, up from 21.0 million in 2020. Therefore, the growing prevalence of peripheral and cardiovascular diseases is driving the drug-eluting balloon catheter market.

Key Industry Players
Major companies operating in the drug eluting balloons catheters market report are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips NV, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Mermaid Medical AS, Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Machine Solutions Inc., Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB</b

The drug eluting balloons catheters market report table of contents includes:

1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model